ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2018

Primary Completion Date

January 31, 2021

Study Completion Date

July 31, 2021

Conditions
Steroid-Resistant Nephrotic Syndrome
Interventions
DRUG

Acthar Gel 80 UNT/ML Injectable Solution

Participant will self inject 'Acthar Gel 80 UNT/ML Injectable Solution' 2 x per week for six months.

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

collaborator

University of Minnesota

OTHER

collaborator

Medalytics

UNKNOWN

lead

Rhode Island Hospital

OTHER

NCT03408405 - ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children | Biotech Hunter | Biotech Hunter